FDA Inspection 865572 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006403388

The FDA completed an inspection of Octapharma Plasma, Inc. on February 6, 2014 in Ypsilanti, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 6, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ypsilanti, MI (United States)